Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Massar

Showing results (281-290 of 300) with videos related to

Pageof 30
Sort By:
Genome Biology|July 1, 2026
Integrated lipidomic and transcriptomic profiling of the host response in human malariaWael Abdrabou, Dariga Bolatbay, Issiaka Soulama, et al.
Nature|September 18, 2024
Advanced CMOS manufacturing of superconducting qubits on 300 mm wafersJ Van Damme, S Massar, R Acharya, et al.
Nature Communications|October 10, 2020
Integrative genomic analysis reveals mechanisms of immune evasion in P. falciparum malariaMame Massar Dieng, Aïssatou Diawara, Vinu Manikandan, et al.
European Journal of Heart Failure|November 15, 2022
Effects of empagliflozin on erythropoiesis in heart failure: data from the Empire HF trialCamilla Fuchs Andersen, Massar Omar, Andreas Glenthøj, et al.
American Heart Journal|August 18, 2020
Twelve weeks of treatment with empagliflozin in patients with heart failure and reduced ejection fraction: A double-blinded, randomized, and placebo-controlled trialJesper Jensen, Massar Omar, Caroline Kistorp, et al.
JAMA Network Open|October 11, 2024
Sleep, Well-Being, and Cognition in Medical Interns on a Float or Overnight Call ScheduleStijn A A Massar, Xin Yu Chua, Ruth Leong, et al.
Oncotarget|April 13, 2016
Human mesenchymal stromal cell-secreted lactate induces M2-macrophage differentiation by metabolic reprogrammingSilvia Selleri, Panojot Bifsha, Sara Civini, et al.
American Heart Journal|February 16, 2024
Empagliflozin to elderly and obese patients with increased risk of developing heart failure: Study protocol for the Empire Prevent trial programCamilla Fuchs Andersen, Julie Hempel Larsen, Jesper Jensen, et al.
Mayo Clinic Proceedings|December 21, 2023
Inorganic Nitrite to Amplify the Benefits and Tolerability of Exercise Training in Heart Failure With Preserved Ejection Fraction: The INABLE-Training TrialBarry A Borlaug, Katlyn E Koepp, Yogesh N V Reddy, et al.
Archives of Sexual Behavior|May 8, 2023
Individual Differences in How Desirable People Think They Are as a MateZsófia Csajbók, Zuzana Štěrbová, Gayle Brewer, et al.
Pageof 30

Showing results (281-290 of 300) with videos related to

Sort By:
Pageof 30
Genome Biology|July 1, 2026
Integrated lipidomic and transcriptomic profiling of the host response in human malariaWael Abdrabou, Dariga Bolatbay, Issiaka Soulama, et al.
Nature|September 18, 2024
Advanced CMOS manufacturing of superconducting qubits on 300 mm wafersJ Van Damme, S Massar, R Acharya, et al.
Nature Communications|October 10, 2020
Integrative genomic analysis reveals mechanisms of immune evasion in P. falciparum malariaMame Massar Dieng, Aïssatou Diawara, Vinu Manikandan, et al.
European Journal of Heart Failure|November 15, 2022
Effects of empagliflozin on erythropoiesis in heart failure: data from the Empire HF trialCamilla Fuchs Andersen, Massar Omar, Andreas Glenthøj, et al.
American Heart Journal|August 18, 2020
Twelve weeks of treatment with empagliflozin in patients with heart failure and reduced ejection fraction: A double-blinded, randomized, and placebo-controlled trialJesper Jensen, Massar Omar, Caroline Kistorp, et al.
JAMA Network Open|October 11, 2024
Sleep, Well-Being, and Cognition in Medical Interns on a Float or Overnight Call ScheduleStijn A A Massar, Xin Yu Chua, Ruth Leong, et al.
Oncotarget|April 13, 2016
Human mesenchymal stromal cell-secreted lactate induces M2-macrophage differentiation by metabolic reprogrammingSilvia Selleri, Panojot Bifsha, Sara Civini, et al.
American Heart Journal|February 16, 2024
Empagliflozin to elderly and obese patients with increased risk of developing heart failure: Study protocol for the Empire Prevent trial programCamilla Fuchs Andersen, Julie Hempel Larsen, Jesper Jensen, et al.
Mayo Clinic Proceedings|December 21, 2023
Inorganic Nitrite to Amplify the Benefits and Tolerability of Exercise Training in Heart Failure With Preserved Ejection Fraction: The INABLE-Training TrialBarry A Borlaug, Katlyn E Koepp, Yogesh N V Reddy, et al.
Archives of Sexual Behavior|May 8, 2023
Individual Differences in How Desirable People Think They Are as a MateZsófia Csajbók, Zuzana Štěrbová, Gayle Brewer, et al.
Pageof 30